Navigation Links
MedCath Enters Definitive Agreement to Sell Dayton Heart Hospital to Good Samaritan Hospital-Dayton
Date:3/24/2008

CHARLOTTE, N.C., March 24 /PRNewswire-FirstCall/ -- MedCath Corporation (MedCath) (Nasdaq: MDTH), its physician partners and Good Samaritan Hospital (Dayton, Ohio) jointly announced today that the parties have entered into a definitive agreement pursuant to which Good Samaritan Hospital will acquire substantially all of Dayton Heart Hospital's assets. The total amount being paid is approximately $55.0 million, a portion of which is allocated to customary non-competition obligations. The transaction is expected to close on or about May 16, subject to customary closing conditions.

Net proceeds to MedCath, after estimated income tax related to the gain on sale, are anticipated to total approximately $32.5 million. MedCath will use the proceeds for general corporate purposes, including investment in other hospital projects. Beginning with its second quarter of fiscal 2008, which ends March 31, MedCath will account for Dayton Heart Hospital as an asset held-for-sale for the current and prior reporting periods.

Opened in 1999, Dayton Heart Hospital is a 47-bed hospital focused on providing cardiovascular care to the Dayton community. A member of the Premier Health Partners system, Good Samaritan Hospital (Dayton, Ohio) is a 577-bed, full-service teaching facility with a 75-year history that delivers best-in- care cardiovascular, cancer and orthopedics services. Recently, the Joint Commission awarded gold seal certifications to the hospital's outstanding heart failure, heart attack, breast cancer and artery bypass graft surgery programs. Additionally, HealthGrades, the leading independent quality monitoring organization in the country, named Good Samaritan as a recipient of its 2008 Distinguished Hospital Award for Clinical Excellence, which places it among the top 5 percent of hospitals nationwide.

"We've had a successful engagement with physician partners in Dayton and have changed the landscape for delivery of heart services in Central Ohio, typical of what happens when MedCath teams up with doctors to raise the bar for hospital care. As we continue to evolve MedCath, focusing on future expansion in markets that equal or exceed national population growth rates is high on our list of preferences," said O. Edwin French, MedCath's President and Chief Executive Officer. He added, "This transaction furthers enhances our already-strong balance sheet so that our foray into acquired acute care hospitals is enhanced. And, with this transaction we also continue to shift the mix of business within our portfolio as we expand heart care but expand the ratio of diversified services faster."

MedCath Corporation, headquartered in Charlotte, N.C., is a healthcare provider focused on high acuity services with the diagnosis and treatment of cardiovascular disease being a primary service offering. Following completion of the divestiture of Dayton Heart Hospital, MedCath will own an interest in and operate nine hospitals with a total of 616 licensed beds, located in Arizona, Arkansas, California, Louisiana, New Mexico, South Dakota, and Texas. MedCath is in the process of developing its tenth hospital, which is anticipated to open in fall 2009, in Kingman, Ariz. In addition, MedCath and its subsidiary MedCath Partners provide services in diagnostic and therapeutic facilities in various states.

Parts of this announcement contain forward-looking statements that involve risks and uncertainties, including the closing of an anticipated sale of the assets of Dayton Heart Hospital. Although management believes that these forward-looking statements are based on reasonable assumptions, these assumptions are inherently subject to significant economic, regulatory and competitive uncertainties and contingencies that are difficult or impossible to predict accurately and are beyond our control. Actual results could differ materially from those projected in these forward-looking statements. We do not assume any obligation to update these statements in a news release or otherwise should material facts or circumstances change in ways that would affect their accuracy.

These various risks and uncertainties are described in detail in "Risk Factors" in MedCath's Form 10-K filed with the Securities and Exchange Commission on December 14, 2007, a copy of which is available on the internet site of the Securities and Exchange Commission at http://www.sec.gov.


'/>"/>
SOURCE MedCath Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. MedCath Corporation to Present at the Citi 2008 Small and Mid-Cap Conference
2. MedCath Corporation to Present at the Raymond James 29th Annual Institutional Investors Conference
3. MedCath Announces Venture With Two New Jersey Hospitals
4. MedCath Plans 60-bed Expansion at TexSAn Heart Hospital
5. MedCath Corporation Reports First Quarter Earnings
6. MedCath Corporation to Hold Conference Call on First Quarter Results
7. MedCath Corporation to Present at the 26th Annual JPMorgan Healthcare Conference
8. MedCath Corporation to Present at the BMO Capital Markets 2007 Focus on Healthcare Conference
9. MedCath Corporation Reports Fourth Quarter Earnings and Outlook for Fiscal 2008
10. Haemonetics(R) Software Solutions to Launch Application for Workflow Optimization in Blood Collection Centers
11. Companies Not Fully Tapping Potential of Onsite Health Centers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... August 18, 2017 , ... ... specialized asset-light logistics provider of complex transport solutions for mission-critical and non-discretionary ... Unitrans International Corporation, a division of Roadrunner Transportation Systems, Inc. (NYSE: RRTS). ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... devices. Through an educational webinar, they will present the line of epMotion automated ... learn how easy you can automate everyday pipetting tasks. , Ideal for scientists ...
(Date:8/18/2017)... Woodlands, TX (PRWEB) , ... August 18, 2017 ... ... protection assistance and financial planning services to communities in east Texas, is launching ... Pediatric Brain Tumor Foundation. , Founded in 1991, the Pediatric Brain Tumor Foundation ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... The Golseth ... in the Dallas/Fort Worth area, is spearheading a regional charity campaign organized to provide ... , In early June of this year, Christina and her children returned from out ...
(Date:8/18/2017)... ... August 18, 2017 , ... Alcovit, a lime-flavored beverage that rids the body ... with its product now available through Jet.com. , After 25 years of development, ... drink is designed to quickly detox the body thereby avoiding alcohol-induced hangovers. Whether you’re ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)...  Endo International plc (NASDAQ: ENDP ) ... all known U.S. mesh product liability claims and that ... remaining U.S. claims at reasonable values. Under the agreements, ... quarter of 2017 and continuing through the fourth quarter ... results, the Company intends to increase its mesh product ...
(Date:8/2/2017)... AROMAS, Calif. , Aug. 2, 2017 /PRNewswire/ ... by Continental Who,s Who as a Pinnacle Lifetime ... currently the Key Account Manager at Turing Pharmaceuticals, ... communications, negotiations, troubleshooting and relationship building.                ... has more than 25 years of experience ...
(Date:8/1/2017)... Aug. 1, 2017   CerSci Therapeutics , a ... Texas , has received notice from the National ... of Health (NIH) that it has been awarded a ... over $650,000 in 2017 with an additional $1,000,000 to ... New Drug application of their lead non-opioid drug candidate ...
Breaking Medicine Technology: